Medicine and Dentistry
Hereditary Nonpolyposis Colorectal Cancer
100%
Colorectal Cancer
75%
Adenoma
61%
Colonoscopy
58%
Neoplasm
50%
Colorectal Tumor
48%
Capsule Endoscopy
47%
Polyposis
43%
Polyp
34%
Cancer Risk
26%
Programmed Cell Death
25%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
25%
Diagnosis
21%
Endoscopy
18%
Double-Balloon Enteroscopy
17%
Dysplasia
16%
Colorectal Adenoma
16%
Chemoprophylaxis
15%
Familial Adenomatous Polyposis
15%
Malignant Neoplasm
14%
Beta-Catenin
14%
Colon
13%
Cohort Analysis
13%
Carcinoma
9%
Prospective Cohort Study
9%
Intestine Preparation
9%
Cholestasis
9%
Colon Cancer
9%
Colorectal Polyp
8%
Anatomy
8%
Nonsteroid Antiinflammatory Agent
8%
DNA Mismatch Repair
8%
Randomized Controlled Trial
8%
Liver Transplantation
8%
Roux-en-Y
8%
APC
8%
Carcinogenesis
8%
Endoscopic Retrograde Cholangiopancreatography
8%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand Receptor
8%
Cancer
8%
Prospective Study
7%
Macrogol
6%
Endometrial Cancer
6%
Prevalence
6%
Sulindac
6%
Receptor Expression
6%
Occult Blood Test
6%
Intestine Cancer
6%
Adenoma Cell Line
6%
Systematic Review
6%
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Cancer
43%
Hereditary Nonpolyposis Colorectal Cancer
41%
Polyposis
24%
Adenoma
22%
Syndrome
20%
Neoplasm
19%
Polyp
15%
Familial Adenomatous Polyposis
13%
Non-Steroidal Anti-Inflammatory Drug
12%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
9%
Colorectal Tumor
9%
Colon Cancer
9%
Malignant Neoplasm
7%
Sulindac
7%
Colorectal Carcinoma
6%
Gastrointestinal Hemorrhage
6%
Carcinogenesis
5%
Placebo
5%
Acetylsalicylic Acid
5%
Keyphrases
Lynch Syndrome
29%
Serrated Polyposis Syndrome
20%
Colorectal Cancer
18%
Colorectal Cancer Risk
13%
Adenoma
10%
Hereditary Colorectal Cancer Syndromes
9%
Advanced Neoplasia
9%
Small Bowel Capsule Endoscopy
8%
Capsule Endoscopy
6%
Chromoendoscopy
6%
Colorectal Adenoma
5%
Netherlands
5%
Surveillance Interval
5%
Surveillance Colonoscopy
5%
White Light Endoscopy
5%
Small Bowel Transit
5%
Endometrial Cancer
5%
Pathogenic Variants
5%
Cancer Inpatients
5%